Oncogene-Specific Differences and Outcomes From Immunotherapy in NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Oncogene-Specific Differences in Tumor Mutational Burden, PD-L1 Expression, and Outcomes From Immunotherapy in Non-Small Cell Lung Cancer
J Immunother Cancer 2021 Aug 01;9(8)e002891, MV Negrao, F Skoulidis, M Montesion, K Schulze, I Bara, V Shen, H Xu, S Hu, D Sui, YY Elamin, X Le, ME Goldberg, K Murugesan, CJ Wu, J Zhang, DS Barreto, JP Robichaux, A Reuben, T Cascone, CM Gay, KG Mitchell, L Hong, W Rinsurongkawong, JA Roth, SG Swisher, J Lee, A Tsao, V Papadimitrakopoulou, DL Gibbons, BS Glisson, G Singal, VA Miller, B Alexander, G Frampton, LA Albacker, D Shames, J Zhang, JV HeymachFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.